Pre-treatment levels of anti-HCV core IgM antibodies are closely associated with response to alpha interferon therapy in chronic hepatitis C patients

1997 ◽  
Vol 9 (3) ◽  
pp. 287-291 ◽  
Author(s):  
Marco Tabone ◽  
Paola Secreto ◽  
Carla Marini ◽  
Renato Bonardi ◽  
Marco Boero ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Interferon Therapy ◽  
Alpha Interferon ◽  
Igm Antibodies ◽  
Pre Treatment ◽  
Chronic Hepatitis C Patients

Early prediction of successful alpha-interferon therapy of chronic hepatitis C by core-IgM antibodies to hepatitis C virus

1994 ◽  
Vol 20 (2) ◽  
pp. 305-306 ◽  
Author(s):  
Nicolaos C. Tassopoulos ◽  
Angelos E. Hatzakis ◽  
George V. Papatheodoridis ◽  
Gerassimos Karvountzis ◽  
Hugo Troonen ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C Virus ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Interferon Therapy ◽  
Alpha Interferon ◽  
Early Prediction ◽  
Igm Antibodies

Pre-treatment with prednisolone does not improve the efficacy of subsequent alpha interferon therapy in chronic hepatitis C

2000 ◽  
Vol 33 (1) ◽  
pp. 135-141 ◽  
Author(s):  
Magda Guilera ◽  
Xavier Forns ◽  
Xavier Torras ◽  
Jaime Enríquez ◽  
Susana Coll ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Interferon Therapy ◽  
Alpha Interferon ◽  
Pre Treatment

scholarly journals Acute Hepatitis Induced by Alpha-Interferon in a Patient with Chronic Hepatitis C

2001 ◽  
Vol 15 (5) ◽  
pp. 333-335 ◽  
Author(s):  
Ivan Kraus ◽  
Dinko Vitezic
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Adverse Effects ◽  
Acute Hepatitis ◽  
Chronic Hepatitis C ◽  
Interferon Therapy ◽  
Alpha Interferon ◽  
Aminotransferase Activity ◽  
Immune Mediated ◽  
Very High

Hepatic adverse effects occur very rarely with alpha-interferon therapy. A case of acute hepatitis induced by alpha-interferon in a 33-year-old man with chronic hepatitis C is described. The patient developed acute hepatitis with very high aminotransferase activity and jaundice. After discontinuing alpha-interferon therapy, hepatitis resolved rapidly. The immune-mediated mechanism is the most probable cause of this hepatitis.

Autoimmunity during alpha-interferon therapy for chronic hepatitis C

1993 ◽  
Vol 28 (S5) ◽  
pp. 109-114 ◽  
Author(s):  
M. Yoshikawa ◽  
T. Sakamoto ◽  
A. MitorO ◽  
T. Mochi ◽  
H. Tsujii ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Interferon Therapy ◽  
Alpha Interferon

Long-term follow up of chronic hepatitis C patients after alpha-interferon treatment: A functional study

2001 ◽  
Vol 16 (4) ◽  
pp. 399-405 ◽  
Author(s):  
Edoardo Giannini ◽  
Alberto Fasoli ◽  
Federica Botta ◽  
Emanuela Testa ◽  
Paola Romagnoli ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Alpha Interferon ◽  
Functional Study ◽  
Interferon Treatment ◽  
Long Term Follow Up ◽  
Chronic Hepatitis C Patients

Predictive value of the IL28B polymorphism on the effect of interferon therapy in chronic hepatitis C patients with genotypes 2a and 2b

2011 ◽  
Vol 54 (3) ◽  
pp. 408-414 ◽  
Author(s):  
Tomokazu Kawaoka ◽  
C. Nelson Hayes ◽  
Waka Ohishi ◽  
Hidenori Ochi ◽  
Toshiro Maekawa ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Chronic Hepatitis C ◽  
Predictive Value ◽  
Interferon Therapy ◽  
Il28b Polymorphism ◽  
Chronic Hepatitis C Patients
Sign in / Sign up

Export Citation Format

Share Document